Literature DB >> 28913601

Emergency Neurological Life Support: Approach to the Patient with Coma.

Rhonda S Cadena1, Aarti Sarwal2.   

Abstract

Coma is an acute failure of neuronal systems governing arousal and awareness and represents a medical emergency. When encountering a comatose patient, the clinician must have an organized approach to detect easily remediable causes, prevent ongoing neurologic injury, and determine a hierarchical plan for diagnostic tests, treatments, and neuromonitoring. Coma was chosen as an Emergency Neurological Life Support protocol because timely medical and surgical interventions can be life-saving, and the initial work-up of such patients is critical to establishing a correct diagnosis.

Entities:  

Keywords:  Coma; Consciousness; Critical care; Neurocritical care

Mesh:

Year:  2017        PMID: 28913601     DOI: 10.1007/s12028-017-0452-1

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  11 in total

Review 1.  Non-traumatic coma in children.

Authors:  F J Kirkham
Journal:  Arch Dis Child       Date:  2001-10       Impact factor: 3.791

Review 2.  Approach to the comatose patient.

Authors:  Robert D Stevens; Anish Bhardwaj
Journal:  Crit Care Med       Date:  2006-01       Impact factor: 7.598

3.  FOUR score and Glasgow Coma Scale in predicting outcome of comatose patients: a pooled analysis.

Authors:  Eelco F M Wijdicks; Alejandro A Rabinstein; William R Bamlet; Jay N Mandrekar
Journal:  Neurology       Date:  2011-05-11       Impact factor: 9.910

4.  Assessment of coma and impaired consciousness. A practical scale.

Authors:  G Teasdale; B Jennett
Journal:  Lancet       Date:  1974-07-13       Impact factor: 79.321

5.  Validation of a new coma scale: The FOUR score.

Authors:  Eelco F M Wijdicks; William R Bamlet; Boby V Maramattom; Edward M Manno; Robyn L McClelland
Journal:  Ann Neurol       Date:  2005-10       Impact factor: 10.422

Review 6.  Convulsive-like movements in brainstem stroke.

Authors:  G Saposnik; L R Caplan
Journal:  Arch Neurol       Date:  2001-04

7.  Development of a modified paediatric coma scale in intensive care clinical practice.

Authors:  A Tatman; A Warren; A Williams; J E Powell; W Whitehouse
Journal:  Arch Dis Child       Date:  1997-12       Impact factor: 3.791

Review 8.  Evaluation of coma and brain death.

Authors:  David J Michelson; Stephen Ashwal
Journal:  Semin Pediatr Neurol       Date:  2004-06       Impact factor: 1.636

9.  Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.

Authors:  Harold P Adams; Gregory del Zoppo; Mark J Alberts; Deepak L Bhatt; Lawrence Brass; Anthony Furlan; Robert L Grubb; Randall T Higashida; Edward C Jauch; Chelsea Kidwell; Patrick D Lyden; Lewis B Morgenstern; Adnan I Qureshi; Robert H Rosenwasser; Phillip A Scott; Eelco F M Wijdicks
Journal:  Circulation       Date:  2007-05-22       Impact factor: 29.690

Review 10.  Paediatric coma scales.

Authors:  Fenella J Kirkham; Charles R J C Newton; William Whitehouse
Journal:  Dev Med Child Neurol       Date:  2008-02-27       Impact factor: 5.449

View more
  2 in total

1.  The accuracy of initial diagnoses in coma: an observational study in 835 patients with non-traumatic disorder of consciousness.

Authors:  Maximilian Lutz; Martin Möckel; Tobias Lindner; Christoph J Ploner; Mischa Braun; Wolf Ulrich Schmidt
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2021-01-12       Impact factor: 2.953

2.  The diagnostic value of the neurological examination in coma of unknown etiology.

Authors:  Wolf U Schmidt; M Lutz; C J Ploner; M Braun
Journal:  J Neurol       Date:  2021-04-01       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.